Drug Profile
Hirugen
Alternative Names: BG 8865Latest Information Update: 22 Jan 2013
Price :
$50
*
At a glance
- Originator Biogen
- Developer Abbott Laboratories; Biogen
- Class Antithrombotics
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Myocardial infarction; Thrombosis